US
Ubraj Singh
About Ubraj Singh
Data last updated:
Ubraj Singh is a Director at Ubix Bioscience Private Limited (since 2022). The companies operate in Pharma and Healthcare. Ubix Bioscience Private Limited reported revenue of ₹1.86 Cr (FY 2024). Earlier, Ubraj Singh was a Director at Zalix Pharmaceuticals Private Limited (2018–2021) and Director at Zymes Bioscience Private Limited (2018–2021) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ubix Bioscience Private Limited U51909UR2021PTC012427 | Director | 13 May 2022 | 2021 | ₹1.86 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Zalix Pharmaceuticals Private Limited U74993DL2018PTC333678 | Director | 27 Jul 2018 | 2018 | Active | |
 Zymes Bioscience Private Limited U51102DL2012PTC234105 | Director | 16 Mar 2018 | 2012 | ₹49.64 Cr (FY 2025) | Active |
 Fenley Rosh Healthcare Private Limited U51909DL2012PTC243615 | Director | 15 Oct 2012 | 2012 | ₹18.7 Lakh (FY 2016) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ubraj Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ankush Cheema | 09265808 | Ubix Bioscience Private Limited | Director |
| Shailu Singh | 09034768 | Ubix Bioscience Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ubraj Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ubraj Singh
Ubraj Singh currently holds 1 directorship: Ubix Bioscience Private Limited (Director, since 13 May 2022, revenue ₹1.86 Cr (FY 2024)).
Ubraj Singh was first appointed on 15 Oct 2012 as Director at Fenley Rosh Healthcare Private Limited. The most recent appointment on record is 13 May 2022 at Ubix Bioscience Private Limited.
Ubraj Singh held 3 earlier board appointments: Zalix Pharmaceuticals Private Limited (Director, 27 Jul 2018 to 22 May 2021); Zymes Bioscience Private Limited (Director, 16 Mar 2018 to 22 May 2021); Fenley Rosh Healthcare Private Limited (Director, 15 Oct 2012 to 19 Dec 2012).
The current boards of Ubraj Singh's companies include Ankush Cheema (Ubix Bioscience Private Limited), Shailu Singh (Ubix Bioscience Private Limited).